Editorial introductions

Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Bernard Y.-H. ThongBernard Y.-H. ThongDr Thong completed his senior residency in Rheumatology and Clinical Immunology/Allergy at Tan Tock Seng Hospital, Singapore from 1999–2002. This was followed by a clinical fellowship in paediatric and adult Clinical Immunology/Allergy at the University of Southampton and Southampton General Hospital, United Kingdom from 2002–2003. He is Senior Consultant at the Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital; and Adjunct Associate Professor and Lead for Rheumatology at the Lee Kong Chian School of Medicine. He has authored/co-authored over 70 peer-reviewed publications in clinical immunology/allergy and rheumatology. He is a member of the World Allergy Organization's Anaphylaxis Special Committee, board member of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APCAACI), associate editor for APAllergy (the official journal of APAAACI) and a member of the editorial board for the journal Allergy. Miguel BlancaMiguel BlancaDr Miguel Blanca graduated from the Faculty of Medicine, University of Granada, Spain, in 1975. He undertook specialist training in allergy from 1976 to 1979 at Carlos Haya Hospital, Malaga, Spain, in the Department of Internal Medicine. Between 1980 and 1982 he undertook further training in allergy and immunology at the Middlesex Hospital, London, UK in the department of Professor Ivan Roit. He was a staff member of the Allergy Unit at Carlos Haya Hospital from 1983 to 1999, and from 1997 to 1999 he was Director of the research unit of Carlos Haya Hospital. Between 2000 and 2003 he was Chief of the Allergy Service at La Paz Hospital, Madrid, Spain. In 2004 he was appointed as Head of the Allergy Service at Carlos Haya Hospital. He has a research group in the BIONAN instituto, Technology Park, Malaga, Spain, a center dedicated to nanomedicine and since 2011 he has been nominated associated Professor at the University of Nancy, France. Since 2008 he has also been the Director of the Spanish National Network for Adverse Reactions to Drugs and Allergens. This consist of a consortium integrated by ten hospitals and five research institutes belonging to different universities and to the Spanish Research Council (CSIC). Dr Blanca has published more than 270 original manuscripts in peer review journals and has received more than 40 grants during his carrier from National and Europeans institutions as well as the pharmaceutical industry. He is a member of the American Academy for Allergy and Immunology, the European Academy of Allergy, the Colegium Allergologicum Internationale and several Spanish national societies and research institutes. Major topics of the research are allergic drug reactions with special dedication to Betalactams and non-steroidal anti-nflammatory drugs, food allergy as well as the local immune response of tissues and organs to allergens and drugs. He has been nominated recently “emeritus son” by the citizens of the village where he was born, Periana (Malaga), Spain. Thomas WerfelThomas WerfelProfessor Werfel is an MD and spent four years as a post-doc in basic immunology before he began his residency at Hannover Medical School, Germany, in the Department of Dermatology. In 1994 he gained Board certification in Dermatology and Allergy and also has a Board membership in Immunology. Since 2008 Professor Werfel has been Head of the Division of Immunodermatology and Allergy Research (Full Professorship) and in addition, the Vice Director of the Department of Dermatology and Allergy at Hannover Medical School. Professor Werfel's research interests focus on chronic inflammatory skin diseases including atopic dermatitis (e.g. role of allergens, microbial antigens and autoantigens in atopic dermatitis, immunology of eczematous skin diseases, new therapeutical approaches in atopic dermatitis). He is currently a member of the Executive Committees of the European Society of Dermatological Research (ESDR), board of the German Society of Dermatology (DDG), is President of the German Society of Allergy and Clinical Immunology (DGAKI). From 1992 he has continuously received research grants from the “Deutsche Forschungsgemeinschaft” (DFG) and from various research foundations and received several awards for his work in allergy and inflammation research. Torsten ZuberbierTorsten ZuberbierTorsten Zuberbier is spokesman of the Allergie-Centrum-Charité within the Department of Dermatology and Allergy at the Charité Berlin. In addition, he is chairman of the European Centre for Allergy Research Foundation (ECARF) and Secretary General of the Global Allergy and Asthma European Network (GA2LEN). Born in Hamburg, Torsten took up his studies of medicine in Antwerp/Belgium and finished his degree at the Freie Universität Berlin. He completed his clinical and scientific education in the field of dermatology at the Charité Virchow Klinikum and wrote his second, postdoctoral dissertation on the differentiation and function of human mast cells. In 2003, he was offered a professorship in connection with the position as Head of Allergy and Co-Director of the Department of Dermatology and Allergy at the Charité Berlin. Torsten's research in the field of dermatology and allergy still focusses on the differentiation and function of human mast cells as well as urticaria, atopic eczema and food allergies. Torsten has published more than 400 papers and is a member of numerous scientific bodies. In 2012, he was awarded an honorary doctorate by the University of Athens. The aim of his dedication to medicine is excellence in research and clinical practice for optimal treatment of patients with skin diseases and allergies. David A. KhanDavid A. KhanDr David A. Khan is Professor of Medicine and Pediatrics at the University of Texas Southwestern Medical Center in Dallas, USA. He is the Program Director for the Allergy & Immunology fellowship program at Southwestern. Dr Khan is a Past-President of the Texas Allergy, Asthma and Immunology Society and is currently on the Board of Directors of the American Academy of Allergy, Asthma, and Immunology. He is also a member of the Joint Task Force on Practice Parameters for Allergy & Immunology. Dr Khan received his medical degree from the University of Illinois in Chicago, USA. After completing an internal medicine residency at the Good Samaritan Medical Center in Phoenix, Arizona, USA, he went on to complete fellowship training in allergy & immunology at the Mayo Clinic, USA. His research interests include drug allergy, alternative therapies for refractory chronic urticaria, mood disorders in asthma, and rush immunotherapy. He has published over 120 peer-reviewed articles. Enrico CompalatiEnrico CompalatiDr Compalati, MD, PhD, graduated in 2001 from Medical School at the University of Genoa, Italy. After his residency in internal medicine, he received his degree in Allergy and Clinical Immunology in 2005. His post-graduate experiences include a PhD-doctorate in Clinical-Experimental Allergy & Respiratory Physiopathology achieved in 2009 and a Master course in Immunotherapy of Allergic and Respiratory Diseases at the same University in 2011. In 2009 he was visiting fellow at the department of Clinical Epidemiology & Biostatistics of the McMaster University, ON, Canada. Currently he is clinician allergist and collaborates with the Allergy and Respiratory Diseases Clinic of the Genoa University, Italy, with particular interests in allergen specific immunotherapy, allergic inflammation, pharmacotherapy of respiratory allergy, food allergy and impact of allergic conditions on health-related quality of life. His scientific activity is mainly focused on the evidence-based methodology of research and clinical trials applied to allergy and respiratory diseases. He is a Cochrane Collaboration's author for the Airways Group, and published several independent systematic reviews, metanalyses and methodological articles. He collaborated with the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) Working Group. From 2008 to February 2014, he was a member of the committee of the World Allergy Organization (WAO) for the Evidence Based Medicine and Methodology and served as author for the Allergy Prevalence Survey by the World Allergy Organization 2007, the WAO Sublingual Immunotherapy Position Paper 2009 and 2013 update, the WAO Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines 2010. He is a member of the interest group for immunotherapy of the European Academy of Allergy and Clinical Immunology (EAACI) and an International-member of the American Academy of Allergy Asthma and Immunology (AAAAI). He is a member of the Panel for Italian Guidelines on Allergic Rhinitis and its Impact on Asthma (ARIA) and leader of the task force on real life projects of the Italian Society of Allergy, Asthma and Clinical Immunology. He is a member of the editorial board for numerous journals in the field of allergy, Associate faculty member of F1000 for Asthma & Allergic Rhinitis, and the author of many different publications in peer-reviewed journals. He has served as lecturer and chair at national and international congresses.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.